Loud Muscle Science: Drug Recall

Recall #D-1340-2022 · 06/27/2022

Class II: Risk

Recall Details

Recall Number: D-1340-2022
Classification: Class II
Product Type: Drug
Recalling Firm: Loud Muscle Science
Status: Terminated
Date Initiated: 06/27/2022
Location: Hauppauge, NY, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1500 10-count tins

Reason for Recall

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Product Description

Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.

Distribution Pattern

The product was distributed nationwide in the USA and Canada.

Other Recalls by Loud Muscle Science

Class I: Dangerous 06/27/2022

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I: Dangerous 06/27/2022

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I: Dangerous 06/27/2022

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class II: Risk 06/27/2022

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.
Class II: Risk 06/27/2022

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

View all recalls by Loud Muscle Science →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.